Global Jet Lag Treatment

Jet Lag Treatment Comprehensive Study by Type (Light therapy, Medications), Application (Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores), Drug (Prescription drugs, Melatonin, Herbal and natural products, OTC (over the counter) drugs), Formulation (Liquid, Tablets), End User (Business travellers, Cabin crew, Athletes, Seasonal travellers) Players and Region - Global Market Outlook to 2030

Jet Lag Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Jet Lag Treatment
The speedy growth in the number of air travellers along with least side-effects or complexities of drugs has been the primary factors driving the jet lag treatment market. Jet lag is a physical disease that happens when the body’s internal clock gets thrown off by a new time zone. Jet Lag Treatment is used to prevent jet lag and nip its sleepy symptoms in the bud. A person may feel drowsy, tired, irritable, lethargic, and slightly disoriented. Then people travel rapidly across time zones or when their sleep is disrupted, for example, because of shift work. The features of jet lag include fatigue, headache, irritability, poor concentration, gastrointestinal disorders, cognitive deficits, and sleep difficulties

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Natrol Inc. (United States), Lucimed (Belgium), Re-Time Pty Ltd. (Australia), Neurim Pharmaceuticals Ltd. (Israel), Pulse Pharmaceuticals Pvt. Ltd. (India), Flynn Pharma Ltd. (United Kingdom), Northern Light Technologies (Australia), Fidia Farmaceutici S.P.A. (Italy), Aspen Pharmacare Holdings Ltd. (South Africa) and Schiff Nutrition International Inc.(United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are The Litebook Company Ltd. (Canada) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Jet Lag Treatment market by Type (Light therapy and Medications), Application (Hospital Pharmacies, Retail Pharmacies, Online Sales and Drug Stores) and Region.



On the basis of geography, the market of Jet Lag Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug , the sub-segment i.e. Prescription drugs will boost the Jet Lag Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Formulation, the sub-segment i.e. Liquid will boost the Jet Lag Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Business travellers will boost the Jet Lag Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
New technological innovations in jet lag treatment market such as the introduction of wearable light therapy devices

Market Growth Drivers:
Increasing geriatric population across the globe and An increasing issue of jet lag among the populace such as pilots, flight attendants and business travellers

Challenges:
Lack of awareness regarding the Jet Lag

Restraints:
Strict governmental rules and regulations on Jet Lag treatment

Opportunities:
The rapid increase in the number of air travellers along with minimal side-effects or complications of drugs has been the primary factors driving the jet lag treatment market.

In April 2022, Superdrug has launched a new travel service that will involve offering patients melatonin tablets to counter jet lag.


Key Target Audience
New entrants/investors, Analysts and strategic business planners, Jet Lag Treatment Provider, Government regulatory and research organizations and End-use industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Light therapy
  • Medications
By Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Drug Stores
By Drug
  • Prescription drugs
  • Melatonin
  • Herbal and natural products
  • OTC (over the counter) drugs

By Formulation
  • Liquid
  • Tablets

By End User
  • Business travellers
  • Cabin crew
  • Athletes
  • Seasonal travellers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing geriatric population across the globe
      • 3.2.2. An increasing issue of jet lag among the populace such as pilots, flight attendants and business travellers
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness regarding the Jet Lag
    • 3.4. Market Trends
      • 3.4.1. New technological innovations in jet lag treatment market such as the introduction of wearable light therapy devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Jet Lag Treatment, by Type, Application, Drug , Formulation, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Jet Lag Treatment (Value)
      • 5.2.1. Global Jet Lag Treatment by: Type (Value)
        • 5.2.1.1. Light therapy
        • 5.2.1.2. Medications
      • 5.2.2. Global Jet Lag Treatment by: Application (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Sales
        • 5.2.2.4. Drug Stores
      • 5.2.3. Global Jet Lag Treatment by: Formulation (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Tablets
      • 5.2.4. Global Jet Lag Treatment by: End User (Value)
        • 5.2.4.1. Business travellers
        • 5.2.4.2. Cabin crew
        • 5.2.4.3. Athletes
        • 5.2.4.4. Seasonal travellers
      • 5.2.5. Global Jet Lag Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Jet Lag Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Natrol Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Lucimed (Belgium)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Re-Time Pty Ltd. (Australia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Neurim Pharmaceuticals Ltd. (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pulse Pharmaceuticals Pvt. Ltd. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Flynn Pharma Ltd. (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Northern Light Technologies (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fidia Farmaceutici S.P.A. (Italy)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aspen Pharmacare Holdings Ltd. (South Africa)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Schiff Nutrition International Inc.(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Jet Lag Treatment Sale, by Type, Application, Drug , Formulation, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Jet Lag Treatment (Value)
      • 7.2.1. Global Jet Lag Treatment by: Type (Value)
        • 7.2.1.1. Light therapy
        • 7.2.1.2. Medications
      • 7.2.2. Global Jet Lag Treatment by: Application (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Sales
        • 7.2.2.4. Drug Stores
      • 7.2.3. Global Jet Lag Treatment by: Formulation (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Tablets
      • 7.2.4. Global Jet Lag Treatment by: End User (Value)
        • 7.2.4.1. Business travellers
        • 7.2.4.2. Cabin crew
        • 7.2.4.3. Athletes
        • 7.2.4.4. Seasonal travellers
      • 7.2.5. Global Jet Lag Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Jet Lag Treatment: by Type(USD Million)
  • Table 2. Jet Lag Treatment Light therapy , by Region USD Million (2018-2023)
  • Table 3. Jet Lag Treatment Medications , by Region USD Million (2018-2023)
  • Table 4. Jet Lag Treatment: by Application(USD Million)
  • Table 5. Jet Lag Treatment Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 6. Jet Lag Treatment Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 7. Jet Lag Treatment Online Sales , by Region USD Million (2018-2023)
  • Table 8. Jet Lag Treatment Drug Stores , by Region USD Million (2018-2023)
  • Table 9. Jet Lag Treatment: by Formulation(USD Million)
  • Table 10. Jet Lag Treatment Liquid , by Region USD Million (2018-2023)
  • Table 11. Jet Lag Treatment Tablets , by Region USD Million (2018-2023)
  • Table 12. Jet Lag Treatment: by End User(USD Million)
  • Table 13. Jet Lag Treatment Business travellers , by Region USD Million (2018-2023)
  • Table 14. Jet Lag Treatment Cabin crew , by Region USD Million (2018-2023)
  • Table 15. Jet Lag Treatment Athletes , by Region USD Million (2018-2023)
  • Table 16. Jet Lag Treatment Seasonal travellers , by Region USD Million (2018-2023)
  • Table 17. South America Jet Lag Treatment, by Country USD Million (2018-2023)
  • Table 18. South America Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 19. South America Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 20. South America Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 21. South America Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 22. South America Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 23. Brazil Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 24. Brazil Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 25. Brazil Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 26. Brazil Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 27. Brazil Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 28. Argentina Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 29. Argentina Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 30. Argentina Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 31. Argentina Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 32. Argentina Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 33. Rest of South America Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 36. Rest of South America Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 37. Rest of South America Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 38. Asia Pacific Jet Lag Treatment, by Country USD Million (2018-2023)
  • Table 39. Asia Pacific Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 40. Asia Pacific Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 41. Asia Pacific Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 42. Asia Pacific Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 43. Asia Pacific Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 44. China Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 45. China Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 46. China Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 47. China Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 48. China Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 49. Japan Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 50. Japan Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 51. Japan Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 52. Japan Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 53. Japan Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 54. India Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 55. India Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 56. India Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 57. India Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 58. India Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 59. South Korea Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 60. South Korea Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 61. South Korea Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 62. South Korea Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 63. South Korea Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 64. Taiwan Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 65. Taiwan Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 66. Taiwan Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 67. Taiwan Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 68. Taiwan Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 69. Australia Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 70. Australia Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 71. Australia Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 72. Australia Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 73. Australia Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 77. Rest of Asia-Pacific Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 78. Rest of Asia-Pacific Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 79. Europe Jet Lag Treatment, by Country USD Million (2018-2023)
  • Table 80. Europe Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 81. Europe Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 82. Europe Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 83. Europe Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 84. Europe Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 85. Germany Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 86. Germany Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 87. Germany Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 88. Germany Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 89. Germany Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 90. France Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 91. France Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 92. France Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 93. France Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 94. France Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 95. Italy Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 96. Italy Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 97. Italy Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 98. Italy Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 99. Italy Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 100. United Kingdom Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 101. United Kingdom Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 102. United Kingdom Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 103. United Kingdom Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 104. United Kingdom Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 105. Netherlands Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 106. Netherlands Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 107. Netherlands Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 108. Netherlands Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 109. Netherlands Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 110. Rest of Europe Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 111. Rest of Europe Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 112. Rest of Europe Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 113. Rest of Europe Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 114. Rest of Europe Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 115. MEA Jet Lag Treatment, by Country USD Million (2018-2023)
  • Table 116. MEA Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 117. MEA Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 118. MEA Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 119. MEA Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 120. MEA Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 121. Middle East Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 122. Middle East Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 123. Middle East Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 124. Middle East Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 125. Middle East Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 126. Africa Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 127. Africa Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 128. Africa Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 129. Africa Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 130. Africa Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 131. North America Jet Lag Treatment, by Country USD Million (2018-2023)
  • Table 132. North America Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 133. North America Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 134. North America Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 135. North America Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 136. North America Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 137. United States Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 138. United States Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 139. United States Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 140. United States Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 141. United States Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 142. Canada Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 143. Canada Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 144. Canada Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 145. Canada Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 146. Canada Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 147. Mexico Jet Lag Treatment, by Type USD Million (2018-2023)
  • Table 148. Mexico Jet Lag Treatment, by Application USD Million (2018-2023)
  • Table 149. Mexico Jet Lag Treatment, by Drug USD Million (2018-2023)
  • Table 150. Mexico Jet Lag Treatment, by Formulation USD Million (2018-2023)
  • Table 151. Mexico Jet Lag Treatment, by End User USD Million (2018-2023)
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Jet Lag Treatment: by Type(USD Million)
  • Table 163. Jet Lag Treatment Light therapy , by Region USD Million (2025-2030)
  • Table 164. Jet Lag Treatment Medications , by Region USD Million (2025-2030)
  • Table 165. Jet Lag Treatment: by Application(USD Million)
  • Table 166. Jet Lag Treatment Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 167. Jet Lag Treatment Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 168. Jet Lag Treatment Online Sales , by Region USD Million (2025-2030)
  • Table 169. Jet Lag Treatment Drug Stores , by Region USD Million (2025-2030)
  • Table 170. Jet Lag Treatment: by Formulation(USD Million)
  • Table 171. Jet Lag Treatment Liquid , by Region USD Million (2025-2030)
  • Table 172. Jet Lag Treatment Tablets , by Region USD Million (2025-2030)
  • Table 173. Jet Lag Treatment: by End User(USD Million)
  • Table 174. Jet Lag Treatment Business travellers , by Region USD Million (2025-2030)
  • Table 175. Jet Lag Treatment Cabin crew , by Region USD Million (2025-2030)
  • Table 176. Jet Lag Treatment Athletes , by Region USD Million (2025-2030)
  • Table 177. Jet Lag Treatment Seasonal travellers , by Region USD Million (2025-2030)
  • Table 178. South America Jet Lag Treatment, by Country USD Million (2025-2030)
  • Table 179. South America Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 180. South America Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 181. South America Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 182. South America Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 183. South America Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 184. Brazil Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 185. Brazil Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 186. Brazil Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 187. Brazil Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 188. Brazil Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 189. Argentina Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 190. Argentina Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 191. Argentina Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 192. Argentina Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 193. Argentina Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 194. Rest of South America Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 195. Rest of South America Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 196. Rest of South America Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 197. Rest of South America Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 198. Rest of South America Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 199. Asia Pacific Jet Lag Treatment, by Country USD Million (2025-2030)
  • Table 200. Asia Pacific Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 201. Asia Pacific Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 202. Asia Pacific Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 203. Asia Pacific Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 204. Asia Pacific Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 205. China Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 206. China Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 207. China Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 208. China Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 209. China Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 210. Japan Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 211. Japan Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 212. Japan Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 213. Japan Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 214. Japan Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 215. India Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 216. India Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 217. India Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 218. India Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 219. India Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 220. South Korea Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 221. South Korea Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 222. South Korea Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 223. South Korea Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 224. South Korea Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 225. Taiwan Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 226. Taiwan Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 227. Taiwan Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 228. Taiwan Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 229. Taiwan Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 230. Australia Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 231. Australia Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 232. Australia Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 233. Australia Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 234. Australia Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 235. Rest of Asia-Pacific Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 236. Rest of Asia-Pacific Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 237. Rest of Asia-Pacific Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 238. Rest of Asia-Pacific Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 239. Rest of Asia-Pacific Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 240. Europe Jet Lag Treatment, by Country USD Million (2025-2030)
  • Table 241. Europe Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 242. Europe Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 243. Europe Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 244. Europe Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 245. Europe Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 246. Germany Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 247. Germany Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 248. Germany Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 249. Germany Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 250. Germany Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 251. France Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 252. France Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 253. France Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 254. France Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 255. France Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 256. Italy Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 257. Italy Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 258. Italy Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 259. Italy Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 260. Italy Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 261. United Kingdom Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 262. United Kingdom Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 263. United Kingdom Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 264. United Kingdom Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 265. United Kingdom Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 266. Netherlands Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 267. Netherlands Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 268. Netherlands Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 269. Netherlands Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 270. Netherlands Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 271. Rest of Europe Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 272. Rest of Europe Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 273. Rest of Europe Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 274. Rest of Europe Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 275. Rest of Europe Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 276. MEA Jet Lag Treatment, by Country USD Million (2025-2030)
  • Table 277. MEA Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 278. MEA Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 279. MEA Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 280. MEA Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 281. MEA Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 282. Middle East Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 283. Middle East Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 284. Middle East Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 285. Middle East Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 286. Middle East Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 287. Africa Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 288. Africa Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 289. Africa Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 290. Africa Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 291. Africa Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 292. North America Jet Lag Treatment, by Country USD Million (2025-2030)
  • Table 293. North America Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 294. North America Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 295. North America Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 296. North America Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 297. North America Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 298. United States Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 299. United States Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 300. United States Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 301. United States Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 302. United States Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 303. Canada Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 304. Canada Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 305. Canada Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 306. Canada Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 307. Canada Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 308. Mexico Jet Lag Treatment, by Type USD Million (2025-2030)
  • Table 309. Mexico Jet Lag Treatment, by Application USD Million (2025-2030)
  • Table 310. Mexico Jet Lag Treatment, by Drug USD Million (2025-2030)
  • Table 311. Mexico Jet Lag Treatment, by Formulation USD Million (2025-2030)
  • Table 312. Mexico Jet Lag Treatment, by End User USD Million (2025-2030)
  • Table 313. Research Programs/Design for This Report
  • Table 314. Key Data Information from Secondary Sources
  • Table 315. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Jet Lag Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Jet Lag Treatment: by Application USD Million (2018-2023)
  • Figure 6. Global Jet Lag Treatment: by Formulation USD Million (2018-2023)
  • Figure 7. Global Jet Lag Treatment: by End User USD Million (2018-2023)
  • Figure 8. South America Jet Lag Treatment Share (%), by Country
  • Figure 9. Asia Pacific Jet Lag Treatment Share (%), by Country
  • Figure 10. Europe Jet Lag Treatment Share (%), by Country
  • Figure 11. MEA Jet Lag Treatment Share (%), by Country
  • Figure 12. North America Jet Lag Treatment Share (%), by Country
  • Figure 13. Global Jet Lag Treatment share by Players 2023 (%)
  • Figure 14. Global Jet Lag Treatment share by Players (Top 3) 2023(%)
  • Figure 15. Global Jet Lag Treatment share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Natrol Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Natrol Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Lucimed (Belgium) Revenue, Net Income and Gross profit
  • Figure 20. Lucimed (Belgium) Revenue: by Geography 2023
  • Figure 21. Re-Time Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 22. Re-Time Pty Ltd. (Australia) Revenue: by Geography 2023
  • Figure 23. Neurim Pharmaceuticals Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 24. Neurim Pharmaceuticals Ltd. (Israel) Revenue: by Geography 2023
  • Figure 25. Pulse Pharmaceuticals Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 26. Pulse Pharmaceuticals Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 27. Flynn Pharma Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Flynn Pharma Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 29. Northern Light Technologies (Australia) Revenue, Net Income and Gross profit
  • Figure 30. Northern Light Technologies (Australia) Revenue: by Geography 2023
  • Figure 31. Fidia Farmaceutici S.P.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 32. Fidia Farmaceutici S.P.A. (Italy) Revenue: by Geography 2023
  • Figure 33. Aspen Pharmacare Holdings Ltd. (South Africa) Revenue, Net Income and Gross profit
  • Figure 34. Aspen Pharmacare Holdings Ltd. (South Africa) Revenue: by Geography 2023
  • Figure 35. Schiff Nutrition International Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 36. Schiff Nutrition International Inc.(United States) Revenue: by Geography 2023
  • Figure 37. Global Jet Lag Treatment: by Type USD Million (2025-2030)
  • Figure 38. Global Jet Lag Treatment: by Application USD Million (2025-2030)
  • Figure 39. Global Jet Lag Treatment: by Formulation USD Million (2025-2030)
  • Figure 40. Global Jet Lag Treatment: by End User USD Million (2025-2030)
  • Figure 41. South America Jet Lag Treatment Share (%), by Country
  • Figure 42. Asia Pacific Jet Lag Treatment Share (%), by Country
  • Figure 43. Europe Jet Lag Treatment Share (%), by Country
  • Figure 44. MEA Jet Lag Treatment Share (%), by Country
  • Figure 45. North America Jet Lag Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Natrol Inc. (United States)
  • Lucimed (Belgium)
  • Re-Time Pty Ltd. (Australia)
  • Neurim Pharmaceuticals Ltd. (Israel)
  • Pulse Pharmaceuticals Pvt. Ltd. (India)
  • Flynn Pharma Ltd. (United Kingdom)
  • Northern Light Technologies (Australia)
  • Fidia Farmaceutici S.P.A. (Italy)
  • Aspen Pharmacare Holdings Ltd. (South Africa)
  • Schiff Nutrition International Inc.(United States)
Additional players considered in the study are as follows:
The Litebook Company Ltd. (Canada) , Others
Select User Access Type

Key Highlights of Report


Mar 2024 218 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Jet Lag Treatment Quantitative research analysis
Global Jet Lag Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Natrol Inc. (United States), Lucimed (Belgium), Re-Time Pty Ltd. (Australia), Neurim Pharmaceuticals Ltd. (Israel), Pulse Pharmaceuticals Pvt. Ltd. (India), Flynn Pharma Ltd. (United Kingdom), Northern Light Technologies (Australia), Fidia Farmaceutici S.P.A. (Italy), Aspen Pharmacare Holdings Ltd. (South Africa) and Schiff Nutrition International Inc.(United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"New technological innovations in jet lag treatment market such as the introduction of wearable light therapy devices" is seen as one of major influencing trends for Jet Lag Treatment Market during projected period 2023-2030.
The Jet Lag Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Jet Lag Treatment Report?

Have a Query? Click Here

Other Related Reports

Medical Device Cleaning Comprehensive Study by Type (Automatic Cleaning, Manual Cleaning), Application (Hospital, Clinics, Others), Product Type (Enzymatic Detergents, Non-enzymatic Detergents, Alkal...
$ 3650
Animal Model Services Comprehensive Study by Type (Mice, Rats, Fish, Birds, Cattles, Others), Application (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genet...
$ 3750
Gastrointestinal Cancer Treatment Comprehensive Study by Drug Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Therapy (Immunotherapy, Chemother...
$ 3750
Veterinary Medication Comprehensive Study by Type (Biologics, Pharmaceuticals, Medicated Feed Additives), Deployment Mode (Oral, Parenteral, Suspension, Topical, Carrier), Distribution Channel (Veter...
$ 3800
Advance Wound Care Comprehensive Study by Type (Hydrogels, Hydrocolloids, Foams, Fabrics, Sponges, Alginates), Application (Inpatient Facilities, Outpatient Facilities), Wound types (Penetrating woun...
$ 3750
Environmental Health And Safety Comprehensive Study by Type (EHS Software, EHS Services), Software (Quality and Risk Assessment, Data Analytics, Cost Management, Environmental Compliance, Energy and...
$ 3750